Gsk Announces Board Changes

Di: Everly

GSK today announces that Dr Laurie Glimcher has been appointed to the Board of the Company as a Non-Executive Director and has been deemed a Scientific and Medical

Spero Therapeutics Provides Business Update and Announces

On 17 December, GSK management held a virtual event, „Early pipeline“, featuring a presentation and an interactive Q&A session.

GSK plc announced the following changes to its Board Committee membership: Wendy Becker has been appointed as a member of the Corporate Responsibility Committee

GlaxoSmithKline plc announces changes to its Board GlaxoSmithKline plc today announces that at the company’s Annual General Meeting in 2013, following nine years

GSK today announced the creation of a new Board committee and a number of changes to the membership of the Board and its committees, which will all take effect from 1

Global biopharma company GSK has announced a number of changes to its board and committees, which are set to take effect immediately following the demerger of its consumer healthcare business.

GlaxoSmithKline plc : GSK announces changes to its Board
GlaxoSmithKline plc announces Board and Committee changes
GSK plc Leadership & Management Team Analysis
Stock exchange announcements

GlaxoSmithKline plc (the ‚Company‘) today announces that Manvinder Singh (Vindi) Banga will join GSK’s Board as a Non-Executive Director on 1 September 2015.

Completion of GSK Share ConsolidationGSK announces changes to its Board and Committees

GSK announces the following changes to its Board and Committee structure Recommended. New webinar in 2025: Trends for life sciences quality leaders in 2025 – mastering what

GSK plc announced that Dr. Gavin Screaton will join the Board of the Company as a Non-Executive Director from 1 May 2025. Dr. Screaton’s appointment follows a search to

GSK’s CEO is Emma Walmsley, appointed in Apr 2017, has a tenure of 7.83 years. total yearly compensation is £12.72M, comprised of 10.3% salary and 89.7% bonuses,

GSK plc Announces Board and Committee Changes Feb 21. Gsk plc Announces Approval of Penmenvy, Gsk’S 5-In-1 Meningococcal Vaccine by US FDA Feb 17. See more

GSK announces Board and Committee changes 21 July 2017 | News Dr Glimcher is currently Professor of Medicine at Harvard Medical School and is CEO, President and an Attending

GSK plc has announced that Wendy Becker will join the board of the company as a non-executive director with effect from 1 October 2023. On joining the board, Wendy will

Completion of GSK Share Consolidation
GSK announces Board changes
Board and Committee changes
GSK plc Announces Board and Committee Changes

GSK plc today announces the following change to its Board Committee membership: Having completed over five years as Science Committee Chair, Dr Jesse

GSK plc (LSE/NYSE: GSK) has today announced that Elizabeth (Liz) McKee Anderson will join the Board of the Company as a Non-Executive Director with effect from 1

GSK plc announced that Dr. Gavin Screaton will join the Board of the Company as a Non-Executive Director from 1 May 2025. Dr. Screaton’s appointment follows a search to

GSK plc Announces Board and Committee Changes Feb 21. Gsk plc Announces Approval of Penmenvy, Gsk’S 5-In-1 Meningococcal Vaccine by US FDA Feb 17. GSK plc Provides

GSK plc announced that Elizabeth McKee Anderson will join the Board of the Company as a Non-Executive Director with effect from 1 September 2022. Liz brings significant

GSK today announces that Dr Laurie Glimcher has been appointed to the Board of the Company as a Non-Executive Director and has been deemed a Scientific and Medical

GSK’s CEO is Emma Walmsley, appointed in Apr 2017, has a tenure of 7.75 years. total yearly compensation is £12.72M, comprised of 10.3% salary and 89.7% bonuses,

GlaxoSmithKline plc today announces the following changes to its Board and Committee membership effective 6 May 2021. As previously announced, Dr Anne Beal has

GlaxoSmithKline plc announced that Sir. Christopher Gent will step down as Chairman of GSK at the company’s Annual General Meeting on 7 May 2015. He will be

Browse GSK’s global press release archive for media and investors. Search by keyword or browse by year/business category. Press releases issued by our local operating companies

GSK plc announced that Dr. Gavin Screaton will join the Board of the Company as a Non-Executive Director from 1 May 2025. Dr. Screaton’s appointment follows a search to

GSK plc announced the following change to its Board Committee membership: Having completed over five years as Science Committee Chair, Dr Jesse Goodman will end his

GSK today announces that Dr Laurie Glimcher has been appointed to the Board of the Company as a Non-Executive Director and has been deemed a Scientific and Medical Expert. Dr Glimcher will join the Board on 1

GSK plc has announced that Wendy Becker will join the board of the company as a non-executive director with effect from 1 October 2023. On joining the board, Wendy will

GSK announces, Mr. James Murdoch has been appointed as a Non-Executive Director and will join the Board of the Company from 20/05/09.

Board information Governance Company GSK announces changes to Vaccines and Global Manufacturing & Supply leadership. GlaxoSmithKline plc (LSE/NYSE: GSK) today

GORT

Reviews